• Nullscript as a Probe of Placental Stress Pathways

  2026-09-02

  Nullscript, a histone deacetylase inhibitor, offers a controlled way to test whether epigenetic regulation contributes to nanoplastic-associated placental mitochondrial injury. This article translates recent NMNAT3–NAD+–ferroptosis findings into a practical, hypothesis-driven assay framework while separating established evidence from proposed applications.

• Valemetostat in Relapsed/Refractory Non-Hodgkin Lymphoma

  2026-09-02

  This first-in-human phase 1 study evaluated oral Valemetostat (DS-3201), a dual EZH2/EZH1 inhibitor, across relapsed or refractory non-Hodgkin lymphoma subtypes. Among 90 treated patients, the treatment produced a 54.5% overall response rate in the efficacy population and established 200 mg per day as the recommended phase 2 dose, while also defining important hematologic and infectious safety considerations.

• Tubastatin A: From HDAC6 Biology to Translation

  2026-09-01

  Tubastatin A is a highly selective HDAC6 inhibitor that connects microtubule acetylation with inflammatory signaling and regulated cell death. This thought-leadership article examines how porcine cardiac-arrest data can inform translational study design while clarifying the compound’s value and limitations in cancer biology, neuroprotection, and inflammation research.

• Fluorescein Tyramide in Oxytocin Circuit Mapping

  2026-09-01

  Early life adversity can disrupt innate defensive behavior through altered oxytocin signaling in the superior colliculus. This thought-leadership analysis explains how Fluorescein Tyramide and tyramide signal amplification can help translational researchers convert that mechanistic insight into more sensitive, spatially resolved validation workflows.

• Toremifene Citrate: Designing ER Assays

  2026-08-31

  Toremifene Citrate is an oral selective estrogen receptor modulator with distinct value in mechanism-led breast cancer research. This assay-first guide explains how to connect receptor binding, cellular response, pharmacokinetics, and experimental controls without confusing potency with translational relevance.

• Nicotinamide Riboside Chloride in RGC Translation

  2026-08-31

  A translational framework for using Nicotinamide Riboside Chloride (NIAGEN) to investigate NAD+ biology alongside reproducible iPSC-derived retinal ganglion cell models, with practical guidance on validation, controls, limitations, and disease-model relevance.

• E-64d: From Protease Inhibition to Cell-Death Insight

  2026-08-30

  E-64d is more than a broad intracellular cysteine protease inhibitor: used with time-resolved phenotyping and genetic validation, it can help translational researchers distinguish protease-dependent death from changes in proliferation. This thought-leadership guide connects E-64d to platelet biology, apoptosis, neuroprotection, and cancer research while defining the evidence needed to move from a useful probe toward a credible mechanistic hypothesis.

• mCherry mRNA Workflow for Reliable Cell Labeling

  2026-08-29

  EZ Cap™ mCherry mRNA (5mCTP, ψUTP) provides a practical red fluorescent protein mRNA readout for transfection optimization, cell tracking, and delivery benchmarking. Its Cap 1 structure, modified nucleotides, and approximately 100-nucleotide poly(A) tail support consistent fluorescence while helping limit RNA-triggered cellular stress.

• BBB Surrogate Model for CNS Permeability Screening

  2026-08-28

  The reference study develops a high-throughput LLC-PK1-MOCK/MDR1 Transwell model that combines barrier integrity testing, P-glycoprotein efflux assessment, and correction for lysosomal trapping. Its correlation with unbound brain distribution and validation across 41 compounds supports a more mechanistic approach to prioritizing CNS drug candidates before extensive in vivo testing.

• Novobiocin Sodium: Reading Replication Stress

  2026-08-28

  Novobiocin Sodium is an aminocoumarin antibiotic that enables more than DNA replication inhibition studies. This article explains how time-resolved bacterial protoplast experiments distinguish replication arrest from DNA degradation and downstream membrane or vacuole phenotypes.

• GSK126 EZH2 Inhibitor: Reliable Assay Design

  2026-08-27

  This scenario-based guide explains how GSK126 EZH2 inhibitor (SKU A3446) can improve the design and interpretation of cell viability, proliferation, and cytotoxicity studies. It connects formulation, exposure, EZH2 biology, and vendor-selection decisions to practical cancer epigenetics research workflows.

• Polystyrene Nanoplastics, NMNAT3, and Placental Ferroptosis

  2026-08-27

  This study identifies a mechanistic link between gestational polystyrene nanoplastic exposure, placental NAD+ depletion, mitochondrial energetic failure, and ferritinophagy-mediated ferroptosis. Its integrated metabolomic, cellular, and rescue-based design positions NMNAT3 and nicotinamide metabolism as testable targets for understanding nanoplastic-associated fetal growth restriction.

• Itraconazole and the Autophagy Logic of Biofilm Resistance

  2026-08-26

  Itraconazole is more than a triazole antifungal agent: it is a versatile research probe for connecting fungal sterol biology, CYP3A4-mediated interactions, and adaptive biofilm resistance. This thought-leadership article translates recent PP2A–autophagy findings in Candida albicans into a rigorous framework for evaluating itraconazole across biofilm, host-interaction, and translational infection models.

• Decitabine Workflows for Cancer Epigenetics

  2026-08-26

  Build reproducible Decitabine experiments that separate DNA hypomethylation, tumor suppressor gene reactivation, and cytotoxicity. This practical guide connects dose selection and multi-omic validation with hematopoietic malignancy research, solid tumor epigenetic studies, and immune-focused assays.

• Decitabine: Dose–Time Logic for Cancer Epigenetics

  2026-08-25

  Decitabine, also known as 5-Aza-2'-deoxycytidine, is more than a DNA methyltransferase inhibitor: its biological effect depends on exposure, replication, and recovery. This guide converts foundational mouse toxicology into practical assay decisions for hematopoietic malignancy research and solid tumor epigenetic studies.

8626 records 1/576 page Next 12345 下5页 Last page